Wheeler Bio is a drug manufacturing company that focuses on the discovery and development of therapeutics.In April 2023, Wheeler Bio Inc closed $31 million of their Series A financing round.In October 2022, Wheeler Bio announced the first closing of their Series A financing round co-led by Charles River Laboratories, Echo Investment Capital, ATUM, Floating Point Advisors, Plains Venture Partners and Pine Ridge Ventures.In January 2022, Wheeler Bio announced the closing of a $14M Seed financing round